This record provides bibliographic details and links to the original research. An editorial study breakdown is not available.
Read the original research
Pharmacokinetics and pharmacodynamics of inhaled GLP-1 (MKC253): proof-of-concept studies in healthy normal volunteers and in patients with type 2 diabetes.
Clinical pharmacology and therapeutics, 88(2), 243-50
Citation
Marino, M T; Costello, D; Baughman, R; Boss, A; Cassidy, J; Damico, C; van Marle, S; van Vliet, A; Richardson, P C. (2010). Pharmacokinetics and pharmacodynamics of inhaled GLP-1 (MKC253): proof-of-concept studies in healthy normal volunteers and in patients with type 2 diabetes.. Clinical pharmacology and therapeutics, 88(2), 243-50. https://doi.org/10.1038/clpt.2010.85